Text Size

Data Bank for Eosinophilic Disorders

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Marc Rothenberg, Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier:
NCT00267475
First received: December 15, 2005
Last updated: January 23, 2013
Last verified: January 2013
History of Changes
  Purpose

The purpose of this study is to conduct a translational study in patients with primary eosinophil associated gastrointestinal disorders [EGID] (e.g. eosinophilic esophagitis eosinophilic gastritis, eosinophilic enteritis [EE], eosinophilic colitis, and eosinophilic gastroenteritis [EGE]) with the aim of developing a data bank containing pertinent patient demographic information, tissue samples, and DNA, which will facilitate research on the pathophysiology of inflammatory disorders and the development of a verified successful clinical treatment program.


Condition
Eosinophilic Esophagitis
Gastritis
Enteritis
Eosinophilic Colitis
Eosinophilic Gastroenteritis

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Clinical and Immunological Evaluation of Eosinophil Associated Gastrointestinal Disorders (EGID)

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Children's Hospital Medical Center, Cincinnati:

Estimated Enrollment: 500
Study Start Date: May 2001
Study Completion Date: December 2012
Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Patients diagnosed with an eosinophilic disorder and patients without an eosinophilic disorder to serve as normal controls

Criteria

Patients with an eosinophil associated gastrointestinal disorder (EGID), family members of patients with EGID, or normal controls.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00267475

Locations
United States, Ohio
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States, 45229-3039
Sponsors and Collaborators
Marc Rothenberg
Investigators
Principal Investigator: Marc E. Rothenberg, M.D., Ph.D. Children's Hospital Medical Center, Cincinnati
  More Information

No publications provided

Responsible Party: Marc Rothenberg, MD, PhD, Children's Hospital Medical Center, Cincinnati
ClinicalTrials.gov Identifier: NCT00267475     History of Changes
Other Study ID Numbers: 01-3-15, CSA1002171
Study First Received: December 15, 2005
Last Updated: January 23, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Children's Hospital Medical Center, Cincinnati:
eosinophilic esophagitis
eosinophilic gastritis
eosinophilic enteritis
eosinophilic colitis
eosinophilic gastroenteritis

Additional relevant MeSH terms:
Colitis
Enteritis
Esophagitis
Gastritis
Gastroenteritis
Digestive System Diseases
Gastrointestinal Diseases
Eosinophilic Esophagitis
Eosinophilia
 Colonic Diseases
Intestinal Diseases
Esophageal Diseases
Stomach Diseases
Leukocyte Disorders
Hematologic Diseases
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on May 19, 2013